Definium Therapeutics Inc. Common Shares vs Magna International Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Magna International Inc. Common Stock trades at $63.7 (market cap $17.43B). The key difference: Magna International Inc. Common Stock is far larger — about 3.7× Definium Therapeutics Inc. Common Shares's market cap, and Magna International Inc. Common Stock pays a 3.04% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Magna International Inc. Common Stock for 0 Days on average.
| DFTX | MGA | |
|---|---|---|
Market Cap | $4.71B | $17.43B |
Volume | 1,966,636 | 1,096,759 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $73.05 |
52-Week Low | $10.68 | $43.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $22.47B |
Dividend Yield | — | 3.04% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →